Maastricht Radiation Oncology: Carcinoma, Non-Small-Cell Lung trials

The registry lists 22 Carcinoma, Non-Small-Cell Lung studies with Maastricht Radiation Oncology as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 7Phase 3 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Standard of Care Lifestyle Support for Stage III NSCLC PatientsWithdrawnNCT05287971
• Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II TrialActive, not recruitingNCT04432142
• Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung CancerCompletedNCT03406468Phase 2
• Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour GrowthCompletedNCT03305380
• Detection of Circulating Biomarkers of Immunogenic Cell DeathCompletedNCT02921854Not applicable
• DE-CT in Lung Cancer Proton TherapyWithdrawnNCT02844140Not applicable
• Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.CompletedNCT02109549
• State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of PatientsCompletedNCT02038413
• Time Trends in Waiting Times of NSCLC Patients.WithdrawnNCT01946490
• Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent DiseaseCompletedNCT01941303
• Usefulness of Blood Biomarkers for Overall Survival in NSCLCCompletedNCT01936571
• Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01282450Phase 2
• Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLCCompletedNCT01282437Phase 3
• Nitroglycerin in Non-small Cell Lung CancerTerminatedNCT01210378Phase 2
• Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC)CompletedNCT01207063Phase 2
• Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)CompletedNCT01166204Phase 2
• Radiotherapy for NSCLC to a Individualized MLDCompletedNCT00573040
• Concurrent Chemo-radiation Form NSCLC to a Individualized MLDCompletedNCT00572325
• Phase I Cetuximab and Concurrent Radio-chemotherapyCompletedNCT00522886Phase 1
• Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.CompletedNCT00181545Phase 1
• Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLCCompletedNCT00181532Phase 2
• HI-CHART:Feasibility of High-Dose Accelerated Conformal RadiotherapyCompletedNCT00181506Phase 1/2